• 1. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 2. Enantiomeric two-fold interpenetrated 3D zinc(ii) coordination networks as a catalytic platform: significant difference between water within the cage and trace water in transesterification?
  Eunkyung Choi,Minjoo Ryu,Haeri Lee,Ok-Sang Jung Dalton Trans., 2017,46, 4595-4601
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 5. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283

Introduction to 1-methyl-3-(methylamino)pyrrolidin-2-one hydrochloride (CAS No. 1803561-70-7)

1-methyl-3-(methylamino)pyrrolidin-2-one hydrochloride (CAS No. 1803561-70-7) is a significant compound in the field of pharmaceutical chemistry, exhibiting a unique structural framework that has garnered considerable attention from researchers worldwide. This compound, characterized by its hydrochloride salt form, belongs to the pyrrolidinone class of molecules, which are widely recognized for their diverse biological activities and potential therapeutic applications. The presence of both methylamino and methyl groups in its structure contributes to its complex reactivity and functional versatility, making it a subject of intense study in medicinal chemistry.

The chemical structure of 1-methyl-3-(methylamino)pyrrolidin-2-one hydrochloride can be described as a seven-membered heterocyclic ring containing an oxygen atom, with substituents at the 1-position (methyl group), 3-position (methylamino group), and 2-position (carbonyl group). The hydrochloride salt form enhances its solubility in aqueous solutions, facilitating its use in various biochemical assays and pharmaceutical formulations. This solubility profile is particularly advantageous for drug development, as it allows for easier administration and absorption in vivo.

In recent years, 1-methyl-3-(methylamino)pyrrolidin-2-one hydrochloride has been extensively investigated for its pharmacological properties. Studies have demonstrated its potential as an intermediate in the synthesis of more complex molecules with therapeutic benefits. The compound’s ability to act as a precursor in the development of novel drugs has made it a valuable asset in pharmaceutical research. Furthermore, its structural motif is reminiscent of several known bioactive agents, suggesting that it may possess similar or even enhanced pharmacological effects.

One of the most compelling aspects of 1-methyl-3-(methylamino)pyrrolidin-2-one hydrochloride is its role in the discovery of new therapeutic agents. Researchers have leveraged its scaffold to design molecules with targeted biological activities. For instance, derivatives of this compound have shown promise in preclinical studies as potential treatments for neurological disorders due to their ability to interact with specific neurotransmitter receptors. The flexibility of the pyrrolidinone ring allows for modifications that can fine-tune the pharmacokinetic and pharmacodynamic properties of the resulting compounds.

The synthesis of 1-methyl-3-(methylamino)pyrrolidin-2-one hydrochloride involves multi-step organic reactions that highlight the ingenuity of modern synthetic chemistry. The process typically begins with the formation of the pyrrolidinone core, followed by functionalization at the desired positions using established methodologies such as nucleophilic substitution or condensation reactions. The introduction of the methylamino group at the 3-position and the methyl group at the 1-position requires precise control over reaction conditions to ensure high yield and purity. The final step involves converting the free base into its hydrochloride salt, which is crucial for improving stability and bioavailability.

The pharmacological profile of 1-methyl-3-(methylamino)pyrrolidin-2-one hydrochloride has been explored through both computational modeling and experimental validation. Computational studies have predicted potential binding interactions with various biological targets, including enzymes and receptors implicated in diseases such as cancer and inflammation. These predictions have been validated by experimental assays conducted in vitro, where the compound demonstrated inhibitory effects on key targets relevant to these conditions. Such findings underscore its significance as a lead compound in drug discovery efforts.

Recent advancements in synthetic methodologies have further enhanced the accessibility of 1-methyl-3-(methylamino)pyrrolidin-2-one hydrochloride, enabling larger-scale production for research purposes. Techniques such as flow chemistry and catalytic processes have improved efficiency and reduced costs associated with its synthesis. These innovations are critical for facilitating further exploration of its biological activities and therapeutic potential. Additionally, green chemistry principles have been incorporated into synthetic routes to minimize environmental impact, aligning with global efforts toward sustainable pharmaceutical production.

The versatility of 1-methyl-3-(methylamino)pyrrolidin-2-one hydrochloride extends beyond its role as a standalone therapeutic agent; it also serves as a building block for more complex drug candidates. By incorporating this scaffold into larger molecules, researchers can exploit its known properties while introducing new functionalities that may enhance efficacy or reduce side effects. This modular approach to drug design has led to several promising candidates entering clinical trials, demonstrating the compound’s value in modern medicinal chemistry.

In conclusion,1-methyl-3-(methylamino)pyrrolidin-2-one hydrochloride (CAS No. 1803561-70-7) is a multifaceted compound with significant potential in pharmaceutical research and development. Its unique structural features, coupled with its demonstrated biological activities, make it a valuable asset for scientists seeking to discover new treatments for various diseases. As research continues to uncover new applications and synthetic strategies for this molecule, it is likely to remain at the forefront of medicinal chemistry innovation for years to come.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)